John Ligon, MD

Trials

Studies that name John Ligon, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:37 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT07031765 · Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma

  University of Florida · active not recruiting · Recurrent High-grade Glioma, Grade III Astrocytoma, Oligodendroglioma · principal investigator
• Ph1
  NCT06946680 · IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)

  University of Florida · not yet recruiting · High-grade Glioma, Diffuse Intrinsic Pontine Glioma · principal investigator
• Ph1
  NCT06514898 · Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

  University of Florida · recruiting · Recurrent Group 3 Medulloblastoma, Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma · principal investigator
• Ph1/Ph2
  NCT05660408 · RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors

  University of Florida · active not recruiting · Recurrent Pulmonary Osteosarcoma, Recurrent High-grade Glioma · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 9 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.